Board meeting held on August 28, 2025

The target over the next three to four years is to reach a profitability of ₹500 crore-plus.

As I mentioned, for FY2026-27 we are targeting approximately 300% growth in our profitability.

On a minimum basis, ₹80 to 90 crores of PAT for FY2026-27.

The target over the next three to four years is to reach a profitability of ₹500 crore-plus.

If our Mediclaim Financing AUM was ₹607.88 crore in FY2025-26, we are targeting ₹1,000 crore in that segment alone in FY2026-27.

In FY2026-27, we ourselves are targeting ₹1,500 crore of disbursements in this segment alone.